Zobrazeno 1 - 7
of 7
pro vyhledávání: '"Sangita Roy Chowdhury"'
Autor:
Heba Alkhatib, Jason Conage-Pough, Sangita Roy Chowdhury, Denen Shian, Deema Zaid, Ariel M. Rubinstein, Amir Sonnenblick, Tamar Peretz-Yablonsky, Avital Granit, Einat Carmon, Ishwar N. Kohale, Judy C. Boughey, Matthew P. Goetz, Liewei Wang, Forest M. White, Nataly Kravchenko-Balasha
Publikováno v:
Molecular Cancer, Vol 23, Iss 1, Pp 1-7 (2024)
Abstract Triple negative breast cancer (TNBC) is a heterogeneous group of tumors which lack estrogen receptor, progesterone receptor, and HER2 expression. Targeted therapies have limited success in treating TNBC, thus a strategy enabling effective ta
Externí odkaz:
https://doaj.org/article/6e9c5a225b574c2e9c271b3e30c7bf17
Autor:
Heba Alkhatib, Ariel M. Rubinstein, Swetha Vasudevan, Efrat Flashner-Abramson, Shira Stefansky, Sangita Roy Chowdhury, Solomon Oguche, Tamar Peretz-Yablonsky, Avital Granit, Zvi Granot, Ittai Ben-Porath, Kim Sheva, Jon Feldman, Noa E. Cohen, Amichay Meirovitz, Nataly Kravchenko-Balasha
Publikováno v:
Genome Medicine, Vol 14, Iss 1, Pp 1-17 (2022)
Abstract Background Drug resistance continues to be a major limiting factor across diverse anti-cancer therapies. Contributing to the complexity of this challenge is cancer plasticity, in which one cancer subtype switches to another in response to tr
Externí odkaz:
https://doaj.org/article/1bfb8d0fe62b40729734ee0a48f29698
Autor:
S. Vasudevan, E. Flashner-Abramson, Heba Alkhatib, Sangita Roy Chowdhury, I. A. Adejumobi, D. Vilenski, S. Stefansky, A. M. Rubinstein, N. Kravchenko-Balasha
Publikováno v:
npj Precision Oncology, Vol 5, Iss 1, Pp 1-13 (2021)
Abstract BRAFV600E melanoma patients, despite initially responding to the clinically prescribed anti-BRAFV600E therapy, often relapse, and their tumors develop drug resistance. While it is widely accepted that these tumors are originally driven by th
Externí odkaz:
https://doaj.org/article/3fa3ce4bd8c843c780d29b16c0e89e36
Autor:
Heba Alkhatib, Ibukun Adesoji Adejumobi, Ariel Rubinstein, Sangita Roy Chowdhury, Swetha Vasudevan, Shira Stefansky, Nataly Kravchenko-Balasha
Publikováno v:
Cancers, Vol 13, Iss 5009, p 5009 (2021)
Cancers
Volume 13
Issue 19
Cancers
Volume 13
Issue 19
Simple Summary Patients with Triple Negative Breast Cancer (TNBC) have a poor prognosis due to high inter-tumor heterogeneity and absence of effective targeted treatments. Through quantification of ongoing processes in each individual with TNBC, we p
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::ea4f15028dd0f2fc4b282ebf49a0447d
https://www.mdpi.com/2072-6694/13/19/5009
https://www.mdpi.com/2072-6694/13/19/5009
Autor:
D Vilenski, Swetha Vasudevan, Heba Alkhatib, Ibukun Adesoji Adejumobi, Shira Stefansky, Nataly Kravchenko-Balasha, Efrat Flashner-Abramson, A M Rubinstein, Sangita Roy Chowdhury
Publikováno v:
npj Precision Oncology, Vol 5, Iss 1, Pp 1-13 (2021)
BRAFV600E melanoma patients, despite initially responding to the clinically prescribed anti-BRAFV600E therapy, often relapse, and their tumors develop drug resistance. While it is widely accepted that these tumors are originally driven by the BRAFV60
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::88840c5e1b3a429fa890d09b57974912
https://doi.org/10.1038/s41698-021-00190-3
https://doi.org/10.1038/s41698-021-00190-3
Autor:
S, Vasudevan, E, Flashner-Abramson, Heba, Alkhatib, Sangita, Roy Chowdhury, I A, Adejumobi, D, Vilenski, S, Stefansky, A M, Rubinstein, N, Kravchenko-Balasha
Publikováno v:
NPJ Precision Oncology
BRAFV600E melanoma patients, despite initially responding to the clinically prescribed anti-BRAFV600E therapy, often relapse, and their tumors develop drug resistance. While it is widely accepted that these tumors are originally driven by the BRAFV60
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid________::40950d128478b83951bdc2976b2327a0
https://pubmed.ncbi.nlm.nih.gov/34112933
https://pubmed.ncbi.nlm.nih.gov/34112933
Publikováno v:
Asian Journal of Pharmacy and Pharmacology. 4:582-588
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::db23dc0b046095d2502868e7aae31fca
https://doi.org/10.31024/ajpp.2018.4.5.6
https://doi.org/10.31024/ajpp.2018.4.5.6